share_log

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Leiderman Elisabeth

SEC ·  Nov 8 16:16

Summary by Moomoo AI

Elisabeth Leiderman, associated with bluebird bio, Inc. [BLUE], completed a stock acquisition on November 6, 2024. The transaction involved a grant of 24,900 shares of common stock at no cost. Following the transaction, Leiderman's direct holdings in the company increased to a total of 47,156 shares. The grant is part of the company's compensation structure and reflects the ongoing commitment of its executives to the company's success.
Elisabeth Leiderman, associated with bluebird bio, Inc. [BLUE], completed a stock acquisition on November 6, 2024. The transaction involved a grant of 24,900 shares of common stock at no cost. Following the transaction, Leiderman's direct holdings in the company increased to a total of 47,156 shares. The grant is part of the company's compensation structure and reflects the ongoing commitment of its executives to the company's success.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more